Search

Vaxcyte Inc

Închisă

SectorSănătate

58.13 -3.68

Rezumat

Modificarea prețului

24h

Curent

Minim

57.36

Maxim

58.13

Indicatori cheie

By Trading Economics

Venit

-284M

-605M

EPS

-1.97

Angajați

507

EBITDA

22M

-292M

Recomandări

By TipRanks

Recomandări

Puternic Cumpărare

Prognoză pe 12 luni

+79.94% upside

Dividende

By Acuity

Următoarele câștiguri

2 nov. 2026

Statistici piață

By TradingEconomics

Capitalizare de piață

1.1B

8.9B

Deschiderea anterioară

61.81

Închiderea anterioară

58.13

Sentimentul știrilor

By Acuity

50%

50%

115 / 339 Clasament în Healthcare

Vaxcyte Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

18 sept. 2026, 20:02 UTC

Vaxcyte Inc shares fell sharply, reaching their lowest cumulative return since Thursday and remaining well below the 20-day moving average.

17 sept. 2026, 20:07 UTC

Correlated Moves

Vaxcyte Inc is gaining, likely influenced by the SPDR S&P Biotech ETF's rise following positive Phase 3 results from Moderna's cancer vaccine.

16 sept. 2026, 19:16 UTC

Macro Event

Vaxcyte Inc shares fell amid broader market volatility following the Federal Reserve's 25 basis point interest rate hike, remaining near the lower end of their one-month range.

14 sept. 2026, 20:08 UTC

Vaxcyte Inc shares are higher today, reflecting broader market trends. Earlier in the session, the stock pulled back but remains above Friday's close.

9 sept. 2026, 19:46 UTC

Vaxcyte Inc shares are lower today, fluctuating from an early gain to a mid-afternoon decline. The stock is near its one-month trading range low.

8 sept. 2026, 23:31 UTC

Vaxcyte Inc shares declined in after-hours trading, now below their 20-day moving average and near the lower end of their one-month trading range.

4 sept. 2026, 20:08 UTC

News

Vaxcyte Inc. appointed new executives and accelerated its timeline for trial data, with shares trading lower during Friday's session.

3 sept. 2026, 20:14 UTC

News

Vaxcyte shares are lower in after-market hours following leadership appointments and narrowed guidance for VAX-31 topline data, now expected by October 2026.

2 sept. 2026, 20:08 UTC

Vaxcyte Inc is gaining today, driven by strong performance in the Biotechnology sub-sector, despite earlier pulling back from a session high.

1 sept. 2026, 20:09 UTC

Vaxcyte Inc shares are lower today, influenced by a broad market decline amid rising oil prices and increasing Treasury yields. No specific company news was identified.

31 aug. 2026, 19:16 UTC

Vaxcyte Inc is trading higher since Friday's close, reflecting a positive performance backdrop. Shares remain above their 20-day moving average.

28 aug. 2026, 20:07 UTC

Vaxcyte Inc shares are lower amid a broader market downturn. Rising U.S. Treasury yields and inflation concerns contribute to the decline in equity prices.

25 aug. 2026, 20:07 UTC

Vaxcyte Inc. shares are lower today, having peaked earlier before drifting downwards. The broader market sees a drop in oil prices and Treasury yields.

24 aug. 2026, 19:46 UTC

Vaxcyte Inc's shares are lower amid rising oil prices and geopolitical tensions. No specific company news was identified to explain the decline.

21 aug. 2026, 21:01 UTC

Vaxcyte Inc is trading higher in after-market hours, maintaining a notable increase since Friday's close, amid positive market sentiment.

20 aug. 2026, 23:46 UTC

Vaxcyte Inc shares are lower in after-market hours, with no specific news identified. Broader market declines may be affecting investor sentiment in biotechnology.

19 aug. 2026, 20:02 UTC

Correlated Moves

Vaxcyte Inc. shares are higher during Wednesday's session, continuing a positive trend with strong investor interest. The stock aligns with gains in the biotechnology sector.

14 aug. 2026, 20:06 UTC

Vaxcyte Inc's shares are lower today, breaking a trend of higher closes. This decline aligns with weaker-than-expected U.S. retail sales data for July.

12 aug. 2026, 19:46 UTC

Vaxcyte Inc shares are higher today, supported by broader market gains following positive sentiment from the recent inflation report. The stock remains above its 20-day moving average.

11 aug. 2026, 23:11 UTC

Vaxcyte Inc shares are higher in after-market trading, reflecting positive momentum despite no specific news driving the price action.

10 aug. 2026, 19:56 UTC

Vaxcyte Inc shares are higher, continuing gains since Friday's close, reaching a peak earlier in the session. No specific news was identified for the move.

7 aug. 2026, 21:01 UTC

Vaxcyte Inc shares are lower in after-market hours, continuing a weak trading session without any specific news to explain the decline.

6 aug. 2026, 20:03 UTC

News

Vaxcyte reports a net loss of $284.3 million for Q2. Shares are trading higher as the company anticipates key Phase 3 trial data in 2027.

5 aug. 2026, 19:16 UTC

Vaxcyte Inc. shares are higher today, aligning with broader market trends, despite no specific news identified. The stock remains near its one-month range low.

4 aug. 2026, 20:21 UTC

Vaxcyte Inc. shares are lower in after-market trading, remaining flat since Tuesday's close and positioned below its 20-day moving average.

3 aug. 2026, 19:46 UTC

Vaxcyte Inc's shares are lower today, continuing a decline since Friday. The stock is trading near the lower end of its one-month range.

31 iul. 2026, 19:56 UTC

Correlated Moves

Shares lower amid broader sector sentiment; SPDR S&P Biotech ETF declines.

30 iul. 2026, 18:52 UTC

Vaxcyte Inc's shares are higher today amid strong buying activity, reaching an intraday high but remain below the 20-day moving average.

29 iul. 2026, 18:23 UTC

Vaxcyte Inc is lower in Wednesday's session, breaking a trend of higher daily closes. No specific news was identified to explain the decline.

28 iul. 2026, 18:46 UTC

Vaxcyte Inc. shares are trading lower amid broader market trends and volatility, remaining below the 20-day moving average as bond yields decline.

Comparație

Modificare preț

Vaxcyte Inc Așteptări

Obiectiv de preț

By TipRanks

79.94% sus

Prognoză pe 12 luni

Medie 104.6 USD  79.94%

Maxim 133 USD

Minim 75 USD

În baza a 5 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruVaxcyte Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Puternic Cumpărare

5 ratings

5

Cumpărare

0

Păstrare

0

Vânzare

Sentiment

By Acuity

115 / 339 Clasament în Sănătate

Sentimentul știrilor

Neutral

Volatilitate

Sub medie

Volumul știrilor (RCV)

Medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Vaxcyte Inc

Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine for the prevention of invasive pneumococcal disease. The company also develops VAX-31 to protect against emerging strains and to help address antibiotic resistance; VAX-A1, a novel conjugate vaccine candidate to prevent disease caused by Group A Streptococcus; VAX-PG, a novel protein vaccine candidate targeting keystone pathogen responsible for periodontitis; and VAX-GI to prevent Shigella, a bacterial illness. The company was formerly known as SutroVax, Inc. and changed its name to Vaxcyte, Inc. in May 2020. Vaxcyte, Inc. was incorporated in 2013 and is headquartered in San Carlos, California.